Study Links GLP-1 Drugs to Lower Cancer Risk

(MedPage Today) — CHICAGO — In patients with type 2 diabetes and obesity, use of GLP-1 receptor agonists was associated with a lower risk of obesity-related cancers and death from any cause, a target trial emulation study found.
In a matched…